Predictors of the rate of change in disease activity over time in LUMINA, a multiethnic US cohort of patients with systemic lupus erythematosus: LUMINA LXX

Lupus

Volumn 19, Issue 6, 2010, Pages 727-733

  Zhang, J ^a,b   Gonzalez L A ^a   Roseman, J M ^b   Vila L M ^c   Reveille, J D ^d   Alarcon G S ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Cohort; Disease activity; Ethnicity; Lupus; Rate of change

Indexed keywords

CREATININE; HLA DR ANTIGEN;

ABNORMAL LABORATORY RESULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE DURATION; ETHNIC DIFFERENCE; FEMALE; HEMATOCRIT; HISPANIC; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SYSTEMIC LUPUS ACTIVITY MEASURE REVISED; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES;

COHORT STUDIES; DISEASE PROGRESSION; ETHNIC GROUPS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS;

EID: 77951236071     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309359289     Document Type: Article

References (35)

1. Stoll T., Sutcliffe N., Mach J., Klaghofer R., Isenberg DA Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus-a 5-yr prospective study. Rheumatology (Oxford) 2004 ; 43: 1039-1044. (Pubitemid 39144453)
2. Cook RJ, Gladman DD, Pericak D., Urowitz MB Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J Rheumatol 2000 ; 27: 1892-1895. (Pubitemid 30670482)
3. Alarcon GS, McGwin G. Jr, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum 2001 ; 45: 191-202.
4. Barr SG, Zonana-Nacach A., Magder LS, Petri M. Patterns of disease activity in systemic lupus erythematosus. Arthritis Rheum 1999 ; 42: 2682-2688. (Pubitemid 30327191)
5. Alarcon GS, Roseman J., Bartolucci AA, et al. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum 1998 ; 41: 1173-1180.
6. Alarcon GS, Calvo-Alen J., McGwin G. Jr, et al. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann Rheum Dis 2006 ; 65: 1168-1174. (Pubitemid 44277391)
7. Bertoli AM, Alarcon GS, McGwin G. Jr, et al. Systemic lupus erythematosus in a multiethnic U.S. cohort (LUMINA) XXVII: factors predictive of a decline to low levels of disease activity. Lupus 2006 ; 15: 13-18. (Pubitemid 43266123)
8. Drenkard C., Villa AR, Garcia-Padilla C., Perez-Vazquez ME, Alarcon-Segovia D. Remission of systematic lupus erythematosus. Medicine (Baltimore) 1996 ; 75: 88-98.
9. Ho A., Magder LS, Barr SG, Petri M. Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. Arthritis Rheum 2001 ; 44: 2342-2349. (Pubitemid 32977502)
10. Mirzayan MJ, Schmidt RE, Witte T. Prognostic parameters for flare in systemic lupus erythematosus. Rheumatology (Oxford) 2000 ; 39 (12). 1316-1319. (Pubitemid 32045856)
11. Urowitz MB, Ibanez D., Jerome D., Gladman DD The effect of menopause on disease activity in systemic lupus erythematosus. J Rheumatol 2006 ; 33: 2192-2198. (Pubitemid 44749778)
12. Bertoli AM, Alarcon GS, Calvo-Alen J., Fernandez M., Vila LM, Reveille JD Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease. Arthritis Rheum 2006 ; 54: 1580-1587.
13. Alarcon GS, Friedman AW, Straaton KV, et al. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: Nature vs. Nurture. Lupus 1999 ; 8: 197-209.
14. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982 ; 25: 1271-1277. (Pubitemid 13221242)
15. Hochberg MC Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997 ; 40: 1725.
16. U.S. Department of Commerce, Bureau of the Census. Current population reports, Series P-23, No. 28 and Series P-60, No. 68 and subsequent years, Washington, DC: Housing and Household Economic Statistics Division.
17. Liang MH, Socher SA, Larson MG, Schur PH Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989 ; 32: 1107-1118.
18. Wluka AE, Liang MH, Partridge AJ, et al. Assessment of systemic lupus erythematosus disease activity by medical record review compared with direct standardized evaluation. Arthritis Rheum 1997 ; 40: 57-61.
19. Aarden LA, de Groot ER, Feltkamp TE Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann N Y Acad Sci 1975 ; 254: 505-515.
20. Harris EN Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group. Am J Clin Pathol 1990 ; 94: 476-484.
21. Triplett DA, Barna LK, Unger GA A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification. Thromb Haemost 1993 ; 70: 787-793.
22. Gladman D., Ginzler E., Goldsmith C., et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996 ; 39: 363-369. (Pubitemid 26085211)
23. Reveille JD, Moulds JM, Ahn C., et al. Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum 1998 ; 41: 1161-1172.
24. Engle EW, Callahan LF, Pincus T., Hochberg MC Learned helplessness in systemic lupus erythematosus: analysis using the Rheumatology Attitudes Index. Arthritis Rheum 1990 ; 33: 281-286. (Pubitemid 20098670)
25. Cohen SMR, Kamarck T., Hoberman HN Measuring the functional components of social support. In: Sarason IGSB (ed.), Social Support: Theory, Research and Applications. Boston, MA: Martinus Nijhoff ; 1985. p. 73-94.
26. Pilowsky I. Dimensions of illness behaviour as measured by the Illness Behaviour Questionnaire: a replication study. J Psychosom Res 1993 ; 37: 53-62. (Pubitemid 23040178)
27. Ware JE Jr, Sherbourne CD The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992 ; 30: 473-483.
28. Ibanez D., Gladman D., Urowitz M. Summarizing disease features over time: II. Variability measures of SLEDAI-2K. J Rheumatol 2007 ; 34: 336-340. (Pubitemid 46255751)
29. Mok CC, Wong RW, Lau CS Ovarian failure and flares of systemic lupus erythematosus. Arthritis Rheum 1999 ; 42: 1274-1280. 30 Mok CC, Lau CS, Ho CT, Wong RW Do flares of systemic lupus erythematosus decline after menopause? Scand J Rheumatol 1999 ; 28: 357-362. (Pubitemid 29268966)
30. Fernandez M., Calvo-Alen J., Alarcon GS, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women. Arthritis Rheum 2005 ; 52: 1655-1664. (Pubitemid 40852872)
31. Alarcon GS, McGwin G. Jr, Bartolucci AA, et al. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum 2001 ; 44: 2797-2806.
32. Vila LM, Alarcon GS, McGwin G. Jr, Bastian HM, Fessler BJ, Reveille JD Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. J Rheumatol 2005 ; 32: 2150-2155.
33. Zonana-Nacach A., Salas M., Sanchez ML, Camargo-Coronel A., Bravo-Gatica C., Mintz G. Measurement of clinical activity of systemic lupus erythematosus and laboratory abnormalities: a 12-month prospective study. J Rheumatol 1995 ; 22: 45-49.
34. van den Berg L., Nossent H., Rekvig O. Prior anti-dsDNA antibody status does not predict later disease manifestations in systemic lupus erythematosus. Clin Rheumatol 2006 ; 25: 347-352.
35. Landewe RB The benefits of early treatment in rheumatoid arthritis: confounding by indication, and the issue of timing. Arthritis Rheum 2003 ; 48: 1-5.